The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

President Donald Trump's executive order on drug pricing may threaten Roche's planned $50 billion investment in the U.S. By ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...